Role of Crk oncogene product in physiologic signaling

被引:63
作者
Kiyokawa, E
Mochizuki, N
Kurata, T
Matsuda, M [1 ]
机构
[1] Int Med Ctr Japan, Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628655, Japan
[2] Int Med Ctr Japan, Res Inst, Dept Pathol, Shinjuku Ku, Tokyo 1628655, Japan
来源
CRITICAL REVIEWS IN ONCOGENESIS | 1997年 / 8卷 / 04期
关键词
v-Crk; c-Crk; CrkII; CrkI; CrkL; oncogene; SH2; SH3;
D O I
10.1615/CritRevOncog.v8.i4.30
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
v-Crk is a member of the family of adaptor-type signaling molecules that consist mostly of SH2 and SH3 domains. The cellular homologs of v-Crk includes CrkI, CrkII, and CrkL; these have been isolated from species ranging from lower vertebrates to man. Crk-family proteins are involved in a variety of signaling cascades such as those of growth factor receptor, integrin, T-cell receptor, B-cell antigen receptor, and cytokines. It has been postulated that the primary function of Crk is to recruit cytoplasmic proteins in the vicinity of tyrosine kinases through SH2-phosphotyrosine interaction. Thus, the output from Crk depends on the SH3-binding proteins, which include the C3G guanine nucleotide exchange protein for Rap1, Abl tyrosine kinase, DOCK180, and the Sos guanine nucleotide exchange protein for Ras. The variety of the Crk-binding proteins indicate the pleiotropic function of Crk.
引用
收藏
页码:329 / 342
页数:14
相关论文
共 95 条
  • [1] A potential SH3 domain-binding site in the Crk SH2 domain
    Anafi, M
    Rosen, MK
    Gish, GD
    Kay, LE
    Pawson, T
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (35) : 21365 - 21374
  • [2] BINDING OF SH2 DOMAINS OF PHOSPHOLIPASE-C-GAMMA-1, GAP, AND SRC TO ACTIVATED GROWTH-FACTOR RECEPTORS
    ANDERSON, D
    KOCH, CA
    GREY, L
    ELLIS, C
    MORAN, MF
    PAWSON, T
    [J]. SCIENCE, 1990, 250 (4983) : 979 - 982
  • [3] Andoniou CE, 1996, ONCOGENE, V12, P1981
  • [4] Erythropoietin and interleukin-3 activate tyrosine phosphorylation of CBL and association with CRK adaptor proteins
    Barber, DL
    Mason, JM
    Fukazawa, T
    Reedquist, KA
    Druker, BJ
    Band, H
    DAndrea, AD
    [J]. BLOOD, 1997, 89 (09) : 3166 - 3174
  • [5] The proto-oncogene product c-Crk associates with insulin receptor substrate-1 and 4PS - Modulation by insulin growth factor-1 (IGF) and enhanced IGF-1 signaling
    BeitnerJohnson, D
    Blakesley, VA
    ShenOrr, Z
    Jimenez, M
    Stannard, B
    Wang, LM
    Pierce, J
    LeRoith, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (16) : 9287 - 9290
  • [6] BIRGE RB, 1992, J BIOL CHEM, V267, P10588
  • [7] IDENTIFICATION AND CHARACTERIZATION OF A HIGH-AFFINITY INTERACTION BETWEEN V-CRK AND TYROSINE-PHOSPHORYLATED PAXILLIN IN CT10-TRANSFORMED FIBROBLASTS
    BIRGE, RB
    FAJARDO, JE
    REICHMAN, C
    SHOELSON, SE
    SONGYANG, Z
    CANTLEY, LC
    HANAFUSA, H
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (08) : 4648 - 4656
  • [8] Sphingosine 1-phosphate stimulates tyrosine phosphorylation of Crk
    Blakesley, VA
    BeitnerJohnson, D
    VanBrocklyn, JR
    Rani, S
    ShenOrr, Z
    Stannard, BS
    Spiegel, S
    LeRoith, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (26) : 16211 - 16215
  • [9] Maintenance of human T cell anergy: Blocking of IL-2 gene transcription by activated Rap1
    Boussiotis, VA
    Freeman, GJ
    Berezovskaya, A
    Barber, DL
    Nadler, LM
    [J]. SCIENCE, 1997, 278 (5335) : 124 - 128
  • [10] Interactions of Cbl with two adaptor proteins, Grb2 and Crk, upon T cell activation
    Buday, L
    Khwaja, A
    Sipeki, S
    Farago, A
    Downward, J
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (11) : 6159 - 6163